Sofinnova Investments, Inc. Q1 2020 Filing
Filed May 13, 2020
Portfolio Value
$1.1T
Holdings
64
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (64 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRTXKaruna Therapeutics, Inc. | 1,885,602 | $135.8B | 12.56% | |
| 2 | ASNDAscendis Pharma A/S | 1,109,874 | $125.0B | 11.56% | |
| 3 | NXTCNextcure, Inc | 2,671,856 | $99.0B | 9.16% | |
| 4 | NTRANatera | 3,100,560 | $92.6B | 8.56% | |
| 5 | —Principia Biopharma | 1,417,258 | $84.2B | 7.78% | |
| 6 | YMABUSDY-mAbs Therapeutics, Inc | 2,194,278 | $57.3B | 5.30% | |
| 7 | MRKMerck & Co Inc | 463,795 | $35.7B | 3.30% | |
| 8 | CHRSCoherus BioSciences | 1,933,221 | $31.4B | 2.90% | |
| 9 | GRTXGalera Therapeutics, Inc | 3,083,712 | $29.3B | 2.71% | |
| 10 | ALXNAlexion Pharmaceuticals Inc | 307,300 | $27.6B | 2.55% | |
| 11 | MRUSMerus N.V. | 1,961,039 | $23.7B | 2.19% | |
| 12 | UTHUnited Therapeutics Corp | 233,559 | $22.1B | 2.05% | |
| 13 | AMRNAmarin | 5,208,305 | $20.8B | 1.93% | |
| 14 | VRTXVertex Pharmaceuticals Inc | 85,664 | $20.4B | 1.89% | |
| 15 | BMRNBiomarin Pharmaceutical Inc | 240,046 | $20.3B | 1.88% | |
| 16 | BIIBBiogen Inc | 52,628 | $16.6B | 1.54% | |
| 17 | XLRNAcceleron Pharma Inc | 165,160 | $14.8B | 1.37% | |
| 18 | KNSAKiniksa Pharmaceuticals, Ltd | 922,700 | $14.3B | 1.32% | |
| 19 | —Nucana Biomed Ltd | 2,400,000 | $14.0B | 1.29% | |
| 20 | —Nucana Biomed Ltd | 2,266,666 | $13.2B | 1.22% | |
| 21 | PTCTPTC Therapeutics Inc | 292,217 | $13.0B | 1.21% | |
| 22 | —ObsEva SA | 4,749,623 | $11.4B | 1.06% | |
| 23 | SRPTSarepta Therapeutics Inc | 101,603 | $9.9B | 0.92% | |
| 24 | KALAKala Pharmaceuticals Inc | 1,114,520 | $9.8B | 0.91% | |
| 25 | —MyoKardia Inc | 175,118 | $8.2B | 0.76% | |
| 26 | AFWAlign Technology Inc | 46,500 | $8.1B | 0.75% | |
| 27 | GILDGilead Sciences Inc | 100,000 | $7.5B | 0.69% | Call |
| 28 | —Kala Pharmaceuticals Inc | 737,300 | $6.5B | 0.60% | Put |
| 29 | —Kadmon Holdings Inc | 1,526,178 | $6.4B | 0.59% | |
| 30 | —Chiasma | 1,630,221 | $6.0B | 0.55% | |
| 31 | MIRMMirum Pharmaceuticals Inc | 418,589 | $5.9B | 0.54% | |
| 32 | HRTXHeron Therapeutics Inc | 481,608 | $5.7B | 0.52% | |
| 33 | PBYIPuma Biotechnology Inc | 638,026 | $5.4B | 0.50% | |
| 34 | AM6Amicus Therapeutics Inc | 525,530 | $4.9B | 0.45% | |
| 35 | ITRMIterum Therapeutics | 1,726,514 | $4.7B | 0.43% | |
| 36 | IOVAIovance Biotherapeutics Inc | 150,000 | $4.5B | 0.42% | Call |
| 37 | AXSMAxsome Therapeutics Inc | 73,163 | $4.3B | 0.40% | |
| 38 | ABBVAbbvie Inc | 50,000 | $3.8B | 0.35% | |
| 39 | 2L9Blueprint Medicines Corp | 63,100 | $3.7B | 0.34% | |
| 40 | —Calithera Biosciences Inc | 819,002 | $3.6B | 0.34% | |
| 41 | FIXXEURHomology Medicines Inc | 230,663 | $3.6B | 0.33% | |
| 42 | —Applied Genetic Technologies Corp | 1,062,615 | $3.5B | 0.32% | |
| 43 | —Akero Therapeutics Inc | 150,000 | $3.2B | 0.29% | Put |
| 44 | AKROAkero Therapeutics Inc | 148,415 | $3.1B | 0.29% | |
| 45 | —Entasis Therapeutics Holdings Inc. | 1,180,178 | $3.1B | 0.29% | |
| 46 | OTICEUROtonomy Inc | 1,515,629 | $3.0B | 0.28% | |
| 47 | ALNYAlnylam Pharmaceuticals Inc | 27,100 | $2.9B | 0.27% | Call |
| 48 | TGTXTG Therapeutics Inc | 275,305 | $2.7B | 0.25% | |
| 49 | CCXIEURChemoCentryx Inc | 66,695 | $2.7B | 0.25% | |
| 50 | RIGLUSDRigel Pharmaceuticals Inc | 1,446,318 | $2.3B | 0.21% | |
| 51 | PTCTPTC Therapeutics Inc | 50,000 | $2.2B | 0.21% | Call |
| 52 | CGENCompugen Ltd | 300,000 | $2.2B | 0.20% | |
| 53 | SG7SAGE Therapeutics Inc | 74,430 | $2.1B | 0.20% | |
| 54 | ACRSAclaris Therapeutics | 1,911,573 | $2.0B | 0.18% | |
| 55 | —Zymeworks Inc | 49,989 | $1.8B | 0.16% | |
| 56 | BCRXBioCryst Pharmaceuticals Inc | 815,690 | $1.6B | 0.15% | |
| 57 | —Menlo Therapeutics Inc | 604,829 | $1.6B | 0.15% | |
| 58 | APLSApellis Pharmaceuticals, Inc | 49,580 | $1.3B | 0.12% | |
| 59 | —Mersana Therapeutics Inc | 225,000 | $1.3B | 0.12% | |
| 60 | —Synlogic Inc. | 574,972 | $989.0M | 0.09% | |
| 61 | —Zogenix Inc | 32,983 | $816.0M | 0.08% | |
| 62 | FATEFate Therapeutics Inc | 36,564 | $812.0M | 0.08% | |
| 63 | ITCIEURIntra-Cellular Therapies Inc | 52,005 | $800.0M | 0.07% | |
| 64 | PDSBPDS Biotechnology Corporation | 142,635 | $104.0M | 0.01% |